Parathyroid hormone's enhancement of bones' osteogenic response to loading is affected by ageing in a dose- and time-dependent manner by Meakin, LB et al.
Accepted Manuscript
Parathyroid hormone's enhancement of bones' osteogenic
response to loading is affected by ageing in a dose- and time-
dependent manner
Lee B Meakin, Henry Todd, Peter J Delisser, Gabriel L Galea,
Alaa Moustafa, Lance E Lanyon, Sara H Windahl, Joanna S Price
PII: S8756-3282(17)30054-6
DOI: doi: 10.1016/j.bone.2017.02.009
Reference: BON 11265
To appear in: Bone
Received date: 22 November 2016
Revised date: 18 February 2017
Accepted date: 20 February 2017
Please cite this article as: Lee B Meakin, Henry Todd, Peter J Delisser, Gabriel L Galea,
Alaa Moustafa, Lance E Lanyon, Sara H Windahl, Joanna S Price , Parathyroid hormone's
enhancement of bones' osteogenic response to loading is affected by ageing in a dose-
and time-dependent manner. The address for the corresponding author was captured
as affiliation for all authors. Please check if appropriate. Bon(2016), doi: 10.1016/
j.bone.2017.02.009
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
1 
 
Parathyroid hormone’s enhancement of bones’ osteogenic response to loading is 
affected by ageing in a dose- and time-dependent manner 
 
Dr Lee B Meakin
1*
 PhD, Mr Henry Todd
1*
 MSc, Mr Peter J Delisser
1 
BVSc, Dr Gabriel L 
Galea
1,4
 PhD, Dr Alaa Moustafa
1,2
 PhD, Prof Lance E Lanyon
1
 DSc, Dr Sara H Windahl
1,3 
PhD, Prof Joanna S Price
1
 PhD 
 
1 
School of Veterinary Sciences, University of Bristol, Bristol, UK 
2
 Department of Surgery, Faculty of Veterinary Medicine, Kafr El-Sheikh University, Kafr 
El-Sheikh, Egypt 
3
 Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at the 
University of Gothenburg, Gothenburg, Sweden  
4
 Newlife Birth Defects Research Centre, UCL Great Ormond Street Institute of Child 
Health, UCL, London, UK 
 
Funding:  
GLG and LBM were supported by Wellcome Veterinary Intercalated Training Fellowships 
(088560/Z/09/Z and 092045/Z/10/Z respectively) and GLG is currently supported by a 
Wellcome Postdoctoral Clinical Training Fellowship (107474/Z/15/Z). AM was supported by 
the Egyptian Ministry of Higher Education. SHW was funded by a European Union’s 
Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant 
agreement No 657178, the Swedish Research Council (2013-8252) and the ALF/LUA 
research grant in Gothenburg (161891).  
 
Correspondence should be addressed to:  
Dr Lee B Meakin, School of Veterinary Sciences, University of Bristol, Langford House, 
Bristol BS40 5DU, UK.  
Tel 0044 117 9289420 Email: lee.meakin@bristol.ac.uk 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
2 
 
Parathyroid hormone’s enhancement of bones’ osteogenic response to loading is 
affected by ageing in a dose- and time-dependent manner 
 
Dr Lee B Meakin
1*
 PhD, Mr Henry Todd
1*
 MSc, Mr Peter J Delisser
1 
BVSc, Dr Gabriel L 
Galea
1,4
 PhD, Dr Alaa Moustafa
1,2
 PhD, Prof Lance E Lanyon
1
 DSc, Dr Sara H Windahl
1,3 
PhD, Prof Joanna S Price
1
 PhD 
 
1 
School of Veterinary Sciences, University of Bristol, Bristol, UK 
2
 Department of Surgery, Faculty of Veterinary Medicine, Kafr El-Sheikh University, Kafr 
El-Sheikh, Egypt 
3
 Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at the 
University of Gothenburg, Gothenburg, Sweden  
4
 Newlife Birth Defects Research Centre, UCL Great Ormond Street Institute of Child 
Health, UCL, London, UK 
 
Funding:  
GLG and LBM were supported by Wellcome Veterinary Intercalated Training Fellowships 
(088560/Z/09/Z and 092045/Z/10/Z respectively) and GLG is currently supported by a 
Wellcome Postdoctoral Clinical Training Fellowship (107474/Z/15/Z). AM was supported by 
the Egyptian Ministry of Higher Education. SHW was funded by a European Union’s 
Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant 
agreement No 657178, the Swedish Research Council (2013-8252) and the ALF/LUA 
research grant in Gothenburg (161891).  
 
Correspondence should be addressed to:  
Dr Lee B Meakin, School of Veterinary Sciences, University of Bristol, Langford House, 
Bristol BS40 5DU, UK.  
Tel 0044 117 9289420 Email: lee.meakin@bristol.ac.uk  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
3 
 
Disclosures: 
All authors state they have no conflict of interest.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
4 
 
Abstract 
Decreased effectiveness of bones’ adaptive response to mechanical loading contributes to 
age-related bone loss. In young mice, intermittent administration of parathyroid hormone 
(iPTH) at 20-80μg/kg/day interacts synergistically with artificially applied loading to increase 
bone mass. Here we report investigations on the effect of different doses and duration of 
iPTH treatment on mice whose osteogenic response to artificial loading is impaired by age. 
One group of aged, 19-month-old female C57BL/6 mice were given 0, 25, 50 or 
100μg/kg/day iPTH for 4 weeks. Histological and μCT analysis of their tibiae revealed potent 
iPTH dose-related increases in periosteally-enclosed area, cortical area and porosity with 
decreased cortical thickness. There was practically no effect on trabecular bone. Another 
group were given a submaximal dose of 50 μg/kg/day iPTH or vehicle for 2 or 6 weeks with 
loading of their right tibia three times per week for the final 2 weeks. In the trabecular bone 
of these mice the loading-related increase in BV/TV was abrogated by iPTH primarily by 
reduction in the increase in trabecular number. In their cortical bone, iPTH treatment time-
dependently increased cortical porosity. Loading partially reduced this effect. The osteogenic 
effects of iPTH and loading on periosteally-enclosed area and cortical area were additive but 
not synergistic. Thus in aged, unlike young mice, iPTH and loading appear to have separate 
effects. iPTH alone causes a marked increase in cortical porosity which loading reduces. Both 
iPTH and loading have positive effects on cortical periosteal bone formation but these are 
additive rather than synergistic.  
 
Key words: Ageing, osteoporosis, bone, parathyroid hormone, mechanical loading  
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1.1 Introduction 
Throughout life, bones adapt their architecture to ensure that they are sufficiently robust to 
withstand the habitual levels of mechanical loading to which they are subjected without 
accumulation of excessive microdamage, or sustaining fracture. This functional adaptation, 
achieved by the processes of modelling and remodelling in response to the local strain 
environment engendered by loading, is commonly referred to as the “mechanostat”.[1] With 
increasing age there is failure to maintain the balance between formation and resorption with 
resulting progressive net bone loss.[2] Previous studies by ourselves and others have 
documented that bone’s adaptive responsive to anabolic stimulation by mechanical loading is 
impaired in aged mice.[3-6] It is probable that this reduced ability to respond appropriately to 
mechanical stimulation is a major contributor to the pathogenesis of age-related bone loss.[7] 
Pharmacotherapy targeted at enhancing aged bones response to mechanical loading should 
therefore have the potential to prevent some of the deleterious effects of ageing on bone and 
restore functionally-relevant structure. Intermittent administration of parathyroid hormone 
(iPTH) was, until recently, the only licensed anabolic treatment for osteoporosis.[8]  
The mechanism of action of PTH has been extensively studied in mice and other 
experimental models. PTH acts predominantly through its receptor, PTH1R. Previous studies 
have investigated both tamoxifen-inducible targeted deletion of PTH1R and constitutively 
active PTH receptor (caPTH1R) in osteocytes using a Dmp1-Cre. Deletion of PTH1R in 
osteocytes results in loss of both cortical and trabecular bone[9] although a further study 
documented conflicting results with a high bone mass phenotype.[10] Conversely, mice 
expressing caPTH1R in osteocytes had dramatically increased bone mass, but only when they 
also expressed the Wnt co-receptor LRP5.[11] Furthermore, the caPTHR1 transgenic mice 
demonstrated greatly reduced Sost expression, the gene encoding sclerostin protein which 
negatively regulates Wnt signalling via LRP co-receptors. An additional study using Sost 
overexpressing and knockout mice indicated that reduction of sclerostin appears to contribute 
to some extent to the anabolic effect of PTH.[12] Sclerostin down regulation is also a 
necessary step in bone’s anabolic response to mechanical stimulation[13] suggesting some 
commonality between the mechanisms of action of iPTH and mechanical stimulation. 
A previous study from our laboratory demonstrated that combining iPTH and mechanical 
loading caused a far greater anabolic response than would have been expected from the 
response to either treatment alone in both cortical and trabecular bone compartments of the 
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mouse tibia.[14] Therefore, we hypothesized that iPTH would have the potential to 
“sensitize” aged bone to the anabolic effects of mechanical loading and “rescue” its impaired 
adaptive response. However, to our knowledge, this interaction has only been studied in 
young female mice that have not yet displayed any age-related bone changes. 
Although the effects of iPTH have been extensively studied, to our knowledge there are no 
studies showing the effect of different doses or duration of iPTH treatment in aged mice. 
Because different studies have used different doses and duration of treatment, it is difficult to 
compare the results presented by different groups. Thus, in this study, we aimed to determine 
the effect of different doses and duration of treatment with iPTH alone and the effect of iPTH 
on the response of aged bone to mechanical loading. 
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1.2 Materials and Methods 
1.2.1 Animals 
Nineteen-month-old female C57BL/6 mice were obtained from Charles River Inc. (Margate, 
UK). All mice were allowed free access to water and a maintenance diet containing 0.75% 
calcium (EURodent Diet 22%; PMI Nutrition International, LLC, Brentwood, MO, USA) in a 
12-hour light/dark cycle, with room temperature at 212°C. All cages contained wood 
shavings, bedding and a cardboard tube for environmental enrichment. Female mice were 
housed in groups of up to five animals.[15] All procedures complied with the UK Animals 
(Scientific Procedures) Act 1986 and were reviewed and approved by the University of 
Bristol ethics committee (Bristol, UK). 
 
1.2.2 Dose-response study 
Mice were divided into 4 weight matched groups (n=8 per group) and treated with either 
vehicle (0.9% saline) or PTH (1-34, Cat. No H-4835, Bachem Biosciences, Switzerland) by 
daily subcutaneous injection. PTH was administered at 25, 50 or 100µg/kg/day in 0.9% 
saline. All mice were treated for 28 days and then sacrificed. The left tibia was used for μCT 
scanning and the right hind limb for strain gaging (see ex vivo strain measurements). 
 
1.2.3 Ex vivo strain measurements 
To apply similar magnitudes of peak strain to all groups of mice, we first established the 
load:strain relationship. In each mouse, a single element strain gage (EA-06-015DJ-120, 
Vishay Measurement Group, NC) was bonded longitudinally to the medial aspect of the tibia 
at 37% of its length from the proximal end. This is the site where we have previously 
observed the greatest osteogenic response to axial loading.[14,16-18] Strains were measured 
across a range of peak loads between 3 and 19N, applied using the same electromagnetic 
loading machine used for in vivo loading (ElectroForce 3100; Bose Co., Eden Prairie, MN, 
USA).  
 
1.2.4 Loading studies 
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Mice were treated with either vehicle or 50µg/kg/day PTH (1-34) by daily subcutaneous 
injection. Mice were injected daily for 15 or 40 days for the 2-week (N=7 and N=6 for 
vehicle and iPTH treated mice respectively) and 6-week (N=13 and N=13 for vehicle and 
iPTH treated mice respectively) studies respectively. The right tibiae were subjected to 
external mechanical loading under isoflurane-induced anesthesia three times per week for 
two weeks starting from day 3 or 29 for the 2-week- and 6-week studies respectively. Left 
limbs were used as internal controls as previously validated.[16,19] The protocol for non-
invasive loading of the mouse tibia has been reported previously.[16,20,21] The flexed knee 
and ankle joints are positioned in concave cups; the upper cup containing the knee, is 
attached to an actuator arm of the loading device and the lower cup to a dynamic load cell. 
The tibia is held in place by a 0.5N continuous static pre-load. 40 cycles of dynamic load are 
superimposed with 10s rest intervals between each cycle. The protocol for one cycle consists 
of loading to the target strain (measured on the medial aspect of the tibia at the 37% site from 
the proximal end), hold for 0.05s at the peak strain, and unloading back to the 0.5N pre-load. 
From the strain gage data (see “ex vivo strain measurements”), there was no significant 
difference between vehicle and PTH-treated mice after 29 days of treatment in the 6-week 
loading study. Therefore the same dynamic load of 12.6N and load rate of 216Ns
-1
 was 
applied to both groups of mice in the 6-week loading. 
 
1.2.5 High-resolution CT analysis 
Following sacrifice, lower legs were fixed in 4% PFA for 48hrs at 4C and then stored in 
70% ethanol and whole tibiae imaged using the SkyScan 1172 (Bruker, Kontich, Belgium) 
with a voxel size of 4.8μm (110m3). The scanning, reconstruction and method of analysis 
has been previously reported.[15,22] We evaluated the effect of iPTH on both tibiae and 
changes due to loading in bone volume fraction (BV/TV), trabecular thickness (Tb.Th), 
trabecular number (Tb.N) and trabecular separation (Tb.Sp) in the trabecular region (0.25-
0.75mm distal to the proximal physis) and cortical bone area (Ct.Ar), total cross-sectional 
area inside the periosteal envelope (Tt.Ar), cortical thickness (Ct.Th) and total cortical 
porosity (Ct.Po) at the cortical site (37% from the proximal end), according to ASBMR 
guidelines.[23] Previously-validated, freely available site-specificity software was used to 
analyze whole bones and allow comparisons of the effects of treatment across all sites in the 
bone as previously reported.[18] 
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1.2.6 Fluorescent bone labelling 
Fluorochrome labels were administered twice; calcein on day 1 and alizarin on day 40 (the 
final loading and treatment day). After CT scanning, tibiae from the pilot study were either 
embedded for histology (next section) or fixed in Bürckhardt’s fixative, dehydrated in 
increasing concentrations of EtOH, and embedded in plastic (L R White Resin; Agar 
Scientific, Stansted, UK) for imaging of fluorescent bone labels. Transverse sections of 
200μm thickness sections were obtained for imaging on a confocal microscope using FITC 
and TRITC filters for calcein and alizarin respectively. Sectioning and imaging were 
performed at Pharmatest Services Ltd (Turku, Finland). 
 
1.2.7 Immunohistochemistry 
Remaining tibiae were decalcified for 21 days in 14% EDTA with continuous agitation. The 
solution was changed three times per week and adequate decalcification confirmed by 
imaging using CT and comparing the bone density with surrounding muscle. Bones were 
then processed for histology and wax embedded and sectioned transversely with 6m 
thickness. Sections corresponding to the 37% site of the tibia (measured from the proximal 
end and where bone formation following mechanical loading is maximal[14,16,17]) were 
stained using a standard H&E staining protocol or using the sclerostin, periostin or cathepsin 
K immunostaining protocol. These were as previously described.[24-26] In short, the sections 
were deparaffinised with xylene and rehydrated in decreasing concentrations of ethanol. 
Peroxidase activity was blocked with hydrogen peroxide and unspecific binding was blocked 
by normal rabbit or goat serum before incubation with the primary antibody; cathepsin K 
antibody (1 hour incubation at room temperature, kindly provided as a gift from Professor 
Göran Andersson, Karolinska Institutet), periostin antibody (incubated over night at 4⁰C, 
Abcam, rabbit anti-mouse/human Periostin ab14041) or sclerostin antibody (incubated over 
night at 4⁰C, R&D systems Inc., goat anti mouse Sost AF1589). For the Cathepsin K and 
periostin assays, a goat anti-rabbit secondary antibody (DAKO, #0432) was used, a rabbit 
anti-goat antibody (Dako, E0466) was used for the sclerostin assay. The signal was amplified 
using the vectastain Elite kit (PK 6100, Vector lab) and visualized with DAB (Vector lab, 
ImmPACT DAB kit SK4100). Sclerostin staining in the fibula was quantified by measuring 
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osteocyte sclerostin stain intensity and binarizing to positive or negative staining using a 
grayscale cut off of 170. The fibula was analysed as this bone did not develop dramatic pores 
which precluded analysis of osteocyte staining in the tibia. 
 
1.2.8 Statistical analysis 
Data is presented as mean ± SEM. The effect of load on the strain measurement was assessed 
using linear regression. The effect loading on tibial length was assessed by paired samples t-
test. The effect of iPTH on measures of bone mass and architecture was assessed using a one-
way ANOVA with post-hoc Bonferroni correction. The effect of loading and iPTH on 
measures of bone mass and architecture within the two- and six-week experiment were 
assessed separately using two-way repeated measures ANOVAs to account for the left and 
right limbs being paired within each mouse. The effect of iPTH or vehicle on sclerostin 
expression in the fibula was assessed using an independent samples t-test.  
Statistical comparison of Site Specificity analyses was by mixed model analysis with bone 
site as a fixed categorical parameter, the intervention (loading, PTH) as a fixed effect and an 
intervention by site interaction to account for site-specific responses. Mouse ID was included 
as a random effect. When the effect of the intervention was significant overall, a post-hoc 
Bonferroni correction was applied to identify the individual sites at which the effect was 
significant at p < 0.05. All statistics were performed using SPSS for Windows (version 23, 
IBM, Chicago). 
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1.3 Results 
Bodyweights and tibial lengths did not change significantly in any group over the course of 
the study: There was an average 0.5% loss of bodyweight over 28 days in the pilot dose 
response study (p=0.63), a 2.5% loss over the 17 days in the 2-week study (p=0.31), and a 
1.1% loss over 40 days in the 6-week study (p=0.07). PTH treatment had no significant effect 
on tibial length in either the pilot dose response (p=0.54), the 2-week (p=0.22) or in the 6-
week study (p=0.54). Loading had no effect on tibial length in the 2-week (p=0.52) or the 6-
week study (p=0.15). 
 
1.3.1 The effect of iPTH dose on trabecular and cortical bone in the tibia 
In trabecular bone, there was no clear dose-response effect for any dose of iPTH on any of 
the measured parameters (see Figure 2a-d). There was an isolated significant effect of iPTH 
dose on Tb.Sp due to a significant increase in Tb.Sp with 50µg/kg/day compared to vehicle 
(Figure 2d). In contrast to the small effect of iPTH dose on trabecular bone, in cortical bone 
the response was pronounced and followed a clear dose-response pattern (Figure 2e-i). Tt.Ar 
dose-dependently increased with iPTH (p<0.001, Figure 2e) suggesting periosteal expansion. 
Ct.Ar also dose-dependently increased (p<0.01, Figure 2f), although only with the 
100µg/kg/day dose was a significant difference observed from vehicle in post-hoc 
comparisons. There was no significant effect of iPTH dose on Ma.Ar (p=0.61). iPTH dose-
dependently reduced Ct.Th (p<0.001, Figure 2g). This occurred due to the formation of intra-
cortical pores as indicated by a dose-dependent increase in total porosity (Ct.Po) (p<0.001, 
Figure 2h). 
 
1.3.2 iPTH induces porosity due to intracortical osteoclastic bone resorption 
Examination of fluorescent labels indicated the intra-cortical pore formation identified on 
µCT (Figure 3a) was a dynamic process that occurred within the study period during which 
iPTH was administered (Figure 3b). Sections of tibial cortex from the 37% site were also 
stained using H&E in addition to immunohistochemical stains for cathepsin K, sclerostin and 
periostin. The H&E stain revealed the intracortical pores to contain large multinucleated cells 
with the features of osteoclasts (Figure 3c) that stained positive for cathepsin K (Figure 3d). 
This process was visible, although not so dramatic, after two weeks of iPTH treatment. Two 
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and six weeks of iPTH treatment resulted in a decrease in the number of osteocytes staining 
positive for sclerostin (Figure 3e). Quantification of osteocytic sclerostin staining in the 
fibula demonstrated that this decrease was statistically significant (vehicle 49 ± 7%, iPTH 29 
± 4%, p=0.03, supplementary figure 1). Periostin immunohistochemical staining documented 
strongly positive cells within the intracortical pores (Figure 3f) which, combined with the 
fluorescent images, is highly suggestive of a dynamic remodelling process in response to 
iPTH involving osteoclastic bone resorption and osteoblastic bone formation. 
 
1.3.4 Ex vivo strain gaging 
To determine whether treatment with 50µg/kg/day iPTH for 4 weeks altered the load:strain 
relationship, strain gages were attached to the medial surface of the right tibia at the 37% site. 
Applying various loads to the tibiae and measuring strain revealed a clear linear relationship. 
The gradient of both regression lines was significantly different from zero (p<0.001). There 
was no significant difference between the strains engendered by loading when the vehicle and 
iPTH-treated bones were compared (p=0.92, Figure 4). Linear regression analysis allowed 
calculation of the loads required to apply 1800µε (11.8N) and 1750 (12.6N) at the start of 
the 2-week- and 6-week studies respectively. 
 
1.3.5 The effect of duration of iPTH treatment on trabecular bone; reversal of the effect of 
mechanical loading on trabecular bone in the proximal tibia 
In trabecular bone, there was a significant interaction between the effects of iPTH and 
mechanical loading on BV/TV, both in the 2-week and 6-week studies (Figure 5a). In both 
experiments, BV/TV was significantly increased by 2 weeks of mechanical loading in 
vehicle-treated mice (+84% and +77% respectively), but this effect was abrogated by 
treatment with iPTH (Figure 5a). Loading increased Tb.Th in the two experiments (+22% and 
+ 15% respectively). While 2-week iPTH treatment had no significant effect on Tb.Th, 6-
week treatment with iPTH significantly decreased Tb.Th (-22%, p<0.001), with no 
significant interaction in either study (Figure 5b). The loading induced increase in Tb.N 
(+52% and +62% for the two experiments respectively, Figure 5c) was depleted with 
concurrent iPTH treatment although there was no significant effect of iPTH or interaction. A 
significant interaction was also detected between loading and iPTH on Tb.N when the mice 
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were pre-treated with iPTH for four weeks prior loading. There was no effect of loading or 
iPTH on Tb.Sp (Figure 5d). P-values are reported in Table 1. 
 
1.3.6 The effect of duration of iPTH treatment and loading on cortical bone were additive 
In cortical bone, loading alone increased Tt.Ar in the two- but not six-week experiment 
(Figure 6a). As expected from the pilot dose-response study, iPTH increased Tt.Ar in the 
two- and six-week study (p=0.01, Figure 6a). Loading alone increased Ct.Ar (5% and 6% 
respectively, Figure 6b), although this was only significant in the six-week experiment 
(P<0.001). Ct.Ar was significantly increased by iPTH treatment in both experiments (+18% 
and +13% for the two- and six-week studies respectively), although there was no interaction 
between loading and iPTH treatment in either study. Concurrent iPTH treatment did not 
affect Ct.Th (Figure 6c), but six weeks iPTH treatment lead to a large decrease in Ct.Th 
(p<0.001) while loading caused a mild, but significant, increase (Figure 6c). Two weeks of 
iPTH treatment increased Ct.Po by 1.5-fold, while a further four weeks of iPTH treatment 
with iPTH caused a dramatic increase in Ct.Po (2.5-fold), which was partially decreased by 
mechanical loading (Figure 6d). There was no significant interaction detected between iPTH 
and mechanical loading for any of the measured cortical parameters suggesting the combined 
effects were additive or independent rather than synergistic. P-values are reported in table 1. 
 
1.3.7 The additive effects of iPTH and loading were observed across the length of the tibia 
A unique feature of mechanical loading as an osteoanabolic stimulus is its ability to target 
bone formation to functionally relevant sites. Systemic treatments such as PTH which interact 
with the mechanostat also have the potential to exert site-specific effects. Therefore, we used 
the previously-described site-specificity analysis software,[18] to  map the effects of iPTH 
and loading on Ct.Ar, Tt.Ar and Ct.Th across the entire length of  bones from the six-week 
iPTH study (Figure 7). Loading predominantly increased Ct.Ar and Ct.Th site-specifically in 
the proximal 50% of the tibia, with minimal effects on Tt.Ar in vehicle-treated mice. iPTH 
increased Ct.Ar over the proximal 70% of the tibia while reducing Ct.Th in the proximal 
50%. Loading of iPTH-treated mice increased Tt.Ar and Ct.Ar in sites within the proximal 
30-50% of the tibia and also increasing Ct.Th over the proximal 50% of the tibia. This 
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implies that the effects of combining iPTH and loading are additive across the proximal half 
of the tibia in agreement with the finding at the 37% cortical site (Figure 7).  
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1.4 Discussion 
Although the mechanisms of action of PTH have been extensively studied, the optimal 
experimental conditions to achieve maximum effects in mouse bones have not been reported. 
Thus in different studies, different doses and durations of treatment are used and their effects 
at different skeletal sites of interest analysed, making comparisons between studies difficult. 
Here we report the effect of four doses and two durations of treatment with iPTH alone and 
the effect of iPTH on the response of aged rather than young bone to artificial loading. Our 
data show that in old mice responses to iPTH and loading differ in both their individual and 
combined effects to those we previously reported in young mice [14].  
Analysis of the effects of different doses of iPTH on cortical and trabecular bone in the tibia 
of aged mice demonstrated a dose-dependent effect of iPTH on Tt.Ar and Ct.Ar. This was 
expected as iPTH has previously been reported to be anabolic on both periosteal and 
endosteal surfaces of cortical bone in the distal femur.[27] In contrast, we found no effect of 
iPTH alone on trabecular bone in the proximal tibia despite being previously reported to be 
anabolic in the trabecular bone of the L5 vertebra.[27] This may reflect the lower trabecular 
content of the proximal tibia in aged mice compared with the vertebrae. An unexpected 
finding in the present study was the dramatic intra-cortical remodelling observed in the tibial 
cortex, particularly with the higher doses of iPTH in aged mice. To our knowledge, this 
finding has not been reported with intermittent administration of PTH in mice despite other 
studies using similar doses.[14,27] This difference could reflect the different ages of mice 
and sites of bone analysed. The result is similar to the phenotype previously reported in the 
caPTH1R-Dmp1 mice which was shown to exhibit periosteal and endosteal bone formation 
with marked increases in intracortical remodelling and cortical porosity.[28] Although the 
PTH in our study was administered by daily subcutaneous injection, it is possible that the 
effects of PTH in aged mice are prolonged leading to a phenotype more similar to that 
observed with continuous activation of PTHR1. 
The intracortical pore formation in the aged mice in our current study appears to be a 
dynamic process, Cathepsin K staining demonstrating an influx of osteoclasts in response to 
iPTH. This increased number of osteoclasts indicates that the resorption is by osteoclasts 
rather than any other process such as osteocytic osteolysis [29] and is consistent with PTH’s 
known ability to stimulate bone resorption by enhancing osteoclastogenesis [30]. The 
presence of periostin-positive cells within the pores and evidence of bone mineral deposition 
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(from fluorescent labelling) indicates concomitant osteoblastic bone formation. This suggests 
that iPTH may be stimulating simultaneous bone resorption and formation. 
We had expected from our previous study in young mice [14] that iPTH would interact with 
mechanical loading resulting in proportionally larger increases in bone mass and architecture 
than those previously observed in aged mice.[3] Contrary to our expectation, in trabecular 
bone iPTH abrogated some of the beneficial effects of mechanical loading; for example on 
BV/TV and trabecular number. The proximal tibia of aged mice contains very few trabeculae 
and proportionally fewer than bones such as the vertebra. Nevertheless, the response in aged 
mice is different from that observed in young mice using the same loading model. This 
emphasises the importance of being careful when extrapolating responses in young animals to 
those in old ones. This may be particularly true in the case of PTH as we have recently 
reported basal and loading-responsive transcriptomic differences between tibiae of young and 
aged mice.[31] These include Wnt signalling and bioenergetics processes, both of which are 
involved in the anabolic effects of PTH. [32,33] 
In cortical bone, mechanical loading had the same beneficial effects as those previously 
reported such as a significant increase in cortical area and thickness.[3,6] Some of the 
potentially deleterious effects of iPTH in cortical bone, such as the increase in intracortical 
porosity and decrease in cortical thickness, were partially rescued by mechanical loading. 
This is consistent with previously published data. For example, genetic knock down of the 
BMP1Ra increases cortical porosity which is partially rescued by increased exercise.[34] 
Further elucidation of the different mechanisms of action of iPTH and mechanical loading is 
likely to be informative. In young mice, when iPTH and loading were combined there was a 
potentially synergistic response suggesting some commonality, or at least complementarity, 
between the cellular mechanisms underlying the responses.[14] This we hypothesized to be 
mediated by sclerostin since both loading and iPTH are known to result in its downregulation 
and therefore increased Wnt signalling.[11,24] However, in aged mice although both loading 
[3] and PTH (this study) cause sclerostin down-regulation there does not appear to be any 
evidence of interaction between the two responses in terms at least of (re)modelling. This is 
consistent with a recent study showing that downregulation of Sost mRNA is required for the 
anabolic effects of loading, but not iPTH in young adult mice.[35] Thus it may be that 
deficiencies in the responses of aged mice to iPTH are either independent of sclerostin or 
occur down-stream of its down-regulation, such as in the recruitment or proliferation of 
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osteoblast cells.[36] The protein-level down-regulation of sclerostin with iPTH was sustained 
up to at least six weeks of treatment in the present study, but this did not ‘rejuvenate’ the 
magnitude of bone’s adaptation to mechanical loading to levels expected in young mice. This 
suggests that the age-related impairment of bone’s adaptation to loading is not entirely 
explained by more transient down-regulation of sclerostin [37] impairing sustained Wnt 
signalling activation. 
Osteoblast recruitment and sclerostin regulation are site-specifically influenced by loading 
[3,24], potentially-explaining the apparent restriction of osteogenic responses to axial loading 
to the proximal half of the mouse tibia. The ability of the distal tibia to increase in mass is 
demonstrated by the significant increase in Ct.Ar below the tibia/fibula junction following 
iPTH treatment independently of loading, as identified by site-specificity analysis. This 
analysis provides meaningful additional information and precludes overly-simplistic 
conclusions drawn from analyses of individual sites. For example, if the main analyses of this 
study had focused on the tibial mid-shaft (50% site), no response to loading would have been 
observed and the response to PTH would not have appeared meaningfully increased by 
loading. Site-specificity analysis therefore represents an important experimental refinement 
that should prevent erroneous interpretations of experiments based on results from single 
sites. 
In summary, in aged mice there was only a small effect of iPTH alone on trabecular bone, 
which was independent of dose although treatment (50 µg/kg/day) for six weeks had a 
stronger effect than two weeks. In trabecular bone, iPTH and loading have no positive 
interaction, indeed iPTH appears to reduce the positive effects of loading on trabecular 
number. In contrast, in cortical bone iPTH had a positive osteogenic dose and time-dependent 
effect.  However, in aged mice, unlike in young ones, this effect appears to act independently 
from the osteogenic effect of loading there being no interaction between the two. Thus the 
positive interactions between the osteogenic effects of loading and iPTH seen in young 
animals are not reproduced in old ones where they could therapeutically be most useful. 
Indeed in trabecular bone the positive interactions seen in young animals were replaced with 
negative ones in old ones, iPTH inhibiting loading-induced increases in BV/TV.  These data 
reinforce the caution that must be exercised when extrapolating from young populations to 
old ones. 
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Figure Legends 
Figure 1 – timeline of experiments. a) In the dose response study mice were injected with 0, 
25, 50 or 100µg/kg/day by subcutaneous injection for 28 days and killed on day 29. For the 
loading studies, mice were injected with vehicle or 50µg/kg/day for either b) 15 or c) 40 days 
with loading three times per week for the final two weeks. 
 
Figure 2 – the effect of various doses of iPTH on trabecular and cortical bone mass and 
architecture after 28 days of treatment. Mice were administered 0, 25, 50 or 100µg/kg/day 
and bone analysed by µCT. iPTH had no clear dose response effect on trabecular BV/TV (a), 
Tb.Th (b) or Tb.N (c) but did cause mild variation in Tb.Sp (d). Conversely there was a 
marked increase in Tt.Ar (e), Ct.Ar (f) and Ct.Po (h) with a corresponding decrease in Ct.Th 
(g) as shown in representative images (i). Analysis was by one-way ANOVA with p-values 
indicated on the graphs. Where significant, post-hoc Bonferroni was performed. Bars with the 
same letter above were not significantly different from each other. 
 
Figure 3 – mice were treated with vehicle or 50µg/kg/day for 28 days and the effect on bone 
architecture examined using µCT (a) and fluorescent bone labels (b). Further sections of bone 
were stained with H&E (c) or immunostained for cathepsin K (d), sclerostin (e) or periostin 
(f). Large images are 10 times and insert images are 40 times magnification. Scale bars in 
large images equals 100µm and in insert images 50µm. Osteoclasts were defined as large, 
strongly Cathepsin K stained cells on a bone surface and are indicated by arrows in figure d. 
Examples of sclerostin positive osteocytes are indicated by arrows in figure e. 
 
Figure 4 – the effect of iPTH on the load strain relationship. Tibial stiffness was unaffected 
by treatment with iPTH. 
 
Figure 5 – the effect of 2- and 6-weeks of treatment with vehicle or 50µg/kg/day iPTH on the 
response to loading for trabecular BV/TV (a), Tb.Th (b), Tb.N (c) and Tb.Sp (d). 
Representative 3D reconstructions showing the effect of 6-weeks iPTH on the response to 
loading in the region of trabecular bone analyzed by µCT (e-h). p-values represent results of 
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the two-way repeated measures ANOVA for the 2- and 6-week loading experiments for the 
effect of PTH, loading and their interaction. Significant results are indicated in bold. 
 
 Figure 6 – the effect of 2- and 6-weeks of treatment with vehicle or 50µg/kg/day iPTH on 
the response to loading for Tt.Ar (a), Ct.Ar (b), Ct.Th (c) and Ct.Po (d). Representative 3D 
reconstructions showing the effect of 6-weeks iPTH on the response to loading in the region 
of cortical bone analyzed by µCT (e-h). p-values represent results of the two-way repeated 
measures ANOVA for the 2- and 6-week loading experiments for the effect of PTH, loading 
and their interaction. Significant results are indicated in bold. 
 
Figure 7 – The combination of iPTH and loading additively increased Ct.Ar (a) and Tt.Ar (b) 
predominantly over the proximal half of the tibia. iPTH, but not loading, increased Ct.Ar (a) 
distal to the tibia/fibula junction (approximately 60% of the tibial length). iPTH decreased, 
whereas loading increased Ct.Th (c) in the proximal tibia. 
 
Supplementary Figure 1 - mice were treated with vehicle or 50µg/kg/day for 28 days. The 
fibula was sectioned and immunostained for sclerostin. Scale bars equals 100µm. 
 
Supplementary Figure 2 – mice were treated with vehicle or 50µg/kg/day for 14 days and 
the effect on bone architecture examined using µCT (a). Further sections of bone were 
stained with H&E (b) or immunostained for cathepsin K (c) or sclerostin (d). Large images 
are 10 times and insert images are 40 times magnification. Scale bars in large images equals 
100µm and in insert images 50µm. Osteoclasts were defined as large, strongly Cathepsin K 
stained cells on a bone surface and are indicated by arrows in figure c. Examples of sclerostin 
positive osteocytes are indicated by arrows in figure d. 
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Highlights 
 
iPTH causes dramatic intra-cortical porosity in the aged mouse tibia 
In trabecular bone, iPTH reduced some of the beneficial effects of mechanical loading 
Mechanical loading reverses some of the deleterious effects of iPTH in cortical bone 
The effects of iPTH and mechanical loading were additive 
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